Multicenter assessment of the rapid Unyvero Blood Culture molecular assay
Standard
Multicenter assessment of the rapid Unyvero Blood Culture molecular assay. / Burrack-Lange, Sandra Christina; Personne, Yoann; Huber, Monika; Winkler, Elisabeth; Weile, Jan; Knabbe, Cornelius; Görig, Julia; Rohde, Holger.
in: J MED MICROBIOL, Jahrgang 67, Nr. 9, 09.2018, S. 1294-1301.Publikationen: SCORING: Beitrag in Fachzeitschrift/Zeitung › SCORING: Zeitschriftenaufsatz › Forschung › Begutachtung
Harvard
APA
Vancouver
Bibtex
}
RIS
TY - JOUR
T1 - Multicenter assessment of the rapid Unyvero Blood Culture molecular assay
AU - Burrack-Lange, Sandra Christina
AU - Personne, Yoann
AU - Huber, Monika
AU - Winkler, Elisabeth
AU - Weile, Jan
AU - Knabbe, Cornelius
AU - Görig, Julia
AU - Rohde, Holger
PY - 2018/9
Y1 - 2018/9
N2 - PURPOSE: Bloodstream infections remain an important cause of morbidity and mortality. Rapid diagnosis can reduce the time from empiric antimicrobial therapy to targeted therapy and improve patient outcomes.METHODOLOGY: The fully automated Unyvero Blood Culture (BCU) Application (Curetis GmbH) can identify a broad panel of pathogens (36 analytes covering over 50 pathogens) and 16 antibiotic resistance gene markers simultaneously in about 5 h. The assay was evaluated in three clinical laboratories in comparison to routine microbiological procedures.RESULTS: A total of 207 blood cultures were included in the study, and 90.5 % of the species identified by culture were covered by the Unyvero BCU panel with an overall sensitivity of 96.8 % and specificity of 99.8 %. The time to result was reduced on average by about 34 h. The assay accurately identified 95 % of the species, including 158/164 monomicrobial and 7/9 polymicrobial cultures. The Unyvero BCU Cartridge detected a large number of resistance markers including mecA (n=57), aac(6')aph(2'') (n=40), one vanB resistance gene, and six instances of blaCTX-M.CONCLUSION: The Unyvero BCU Application provided fast, reliable results, while significantly improving turnaround time in blood culture diagnostics.
AB - PURPOSE: Bloodstream infections remain an important cause of morbidity and mortality. Rapid diagnosis can reduce the time from empiric antimicrobial therapy to targeted therapy and improve patient outcomes.METHODOLOGY: The fully automated Unyvero Blood Culture (BCU) Application (Curetis GmbH) can identify a broad panel of pathogens (36 analytes covering over 50 pathogens) and 16 antibiotic resistance gene markers simultaneously in about 5 h. The assay was evaluated in three clinical laboratories in comparison to routine microbiological procedures.RESULTS: A total of 207 blood cultures were included in the study, and 90.5 % of the species identified by culture were covered by the Unyvero BCU panel with an overall sensitivity of 96.8 % and specificity of 99.8 %. The time to result was reduced on average by about 34 h. The assay accurately identified 95 % of the species, including 158/164 monomicrobial and 7/9 polymicrobial cultures. The Unyvero BCU Cartridge detected a large number of resistance markers including mecA (n=57), aac(6')aph(2'') (n=40), one vanB resistance gene, and six instances of blaCTX-M.CONCLUSION: The Unyvero BCU Application provided fast, reliable results, while significantly improving turnaround time in blood culture diagnostics.
KW - Anti-Bacterial Agents
KW - Bacteremia
KW - Bacteria
KW - Bacterial Proteins
KW - Blood Culture
KW - Humans
KW - Multiplex Polymerase Chain Reaction
KW - Polymerase Chain Reaction
KW - Sensitivity and Specificity
KW - Evaluation Studies
KW - Journal Article
KW - Multicenter Study
U2 - 10.1099/jmm.0.000804
DO - 10.1099/jmm.0.000804
M3 - SCORING: Journal article
C2 - 30051799
VL - 67
SP - 1294
EP - 1301
JO - J MED MICROBIOL
JF - J MED MICROBIOL
SN - 0022-2615
IS - 9
ER -